Lobolide, a diterpene, blockades the NF-kappa B pathway and p38 and ERK MAPK activity in macrophages in vitro
文献类型:期刊论文
作者 | Lv, Xiao-fen2; Chen, Si-han1; Li, Jie2; Fang, Jian-ping2; Guo, Yue-wei1![]() ![]() |
刊名 | ACTA PHARMACOLOGICA SINICA
![]() |
出版日期 | 2012-10 |
卷号 | 33期号:10页码:1293-1300 |
关键词 | lobolide diterpene monocytes lipopolysaccharide NF-kappa B TNF alpha IL-1 beta TAK1 Erk 1/2 p38 inflammation |
ISSN号 | 1671-4083 |
DOI | 10.1038/aps.2012.100 |
文献子类 | Article |
英文摘要 | Aim: Recent studies have shown that constitutive activation of the nuclear factor kappa B (NF-kappa B) plays a key role in chronic inflammation and cancers. The aim of this study was to characterize lobolide, a cembrane diterpene, as a drug candidate targeting the NF-kappa B signaling pathway. Methods: A HEK 293/NF-kappa B-luc stable cell line was constructed to evaluate the effect of lobolide on NF-kappa B activation. THP-1 human monocytes and peripheral blood mononuclear cells (PBMCs) from healthy volunteers were tested. Lipopolysaccharide (LPS)-induced TNF alpha and IL-1 beta production and activation of the TAK1-IKK-NF-kappa B pathway were studied using ELISA and Western blot analysis. Results: In HEK 293/NF-kappa B-Luc stable cells, lobolide (0.19-50 mu mol/L) inhibited NF-kappa B activation in a concentration-dependent manner with an IC50 value of 4.2 +/- 0.3 mu mol/L. Treatment with lobolide (2.5-10 mu mol/L) significantly suppressed LPS-induced production of TNF alpha and IL-1 beta in both THP-1 cells and PBMCs. In THP-1 cells, the suppression was partially caused by blockade of the translocation of NF-kappa B from the cytoplasm to the nucleus via affecting the TAK1-IKK-NF-kappa B pathway and p38 and ERK MAPK activity. Conclusion: Lobolide is a potential inhibitor of the NF-kappa B pathway, which blocks the translocation of NF-kappa B from the cytoplasm to the nucleus. Lobolide inhibits LPS-stimulated TNF alpha and IL-1 beta release, suggesting that the compound might be an anti-inflammatory compound. |
WOS关键词 | NONSTEROIDAL ANTIINFLAMMATORY DRUGS ; PROTEIN-KINASE ; LIPOPOLYSACCHARIDE ; ACTIVATION ; CELLS ; TAK1 ; MECHANISMS ; INHIBITORS ; CYTOKINES ; RESPONSES |
资助项目 | National Natural Science Foundation of China[30870551] ; Key New Drug Creation and Manufacturing Program of China[2009ZX09501-011] ; Key New Drug Creation and Manufacturing Program of China[2009ZX09103-071] ; Key New Drug Creation and Manufacturing Program of China[2009ZX09301-001] |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
CSCD记录号 | CSCD:4639822 |
WOS记录号 | WOS:000309656500008 |
出版者 | ACTA PHARMACOLOGICA SINICA |
源URL | [http://119.78.100.183/handle/2S10ELR8/277931] ![]() |
专题 | 天然药物化学研究室 中科院受体结构与功能重点实验室 新药研究国家重点实验室 药理学第三研究室 |
通讯作者 | Guo, Yue-wei |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Lv, Xiao-fen,Chen, Si-han,Li, Jie,et al. Lobolide, a diterpene, blockades the NF-kappa B pathway and p38 and ERK MAPK activity in macrophages in vitro[J]. ACTA PHARMACOLOGICA SINICA,2012,33(10):1293-1300. |
APA | Lv, Xiao-fen,Chen, Si-han,Li, Jie,Fang, Jian-ping,Guo, Yue-wei,&Ding, Kan.(2012).Lobolide, a diterpene, blockades the NF-kappa B pathway and p38 and ERK MAPK activity in macrophages in vitro.ACTA PHARMACOLOGICA SINICA,33(10),1293-1300. |
MLA | Lv, Xiao-fen,et al."Lobolide, a diterpene, blockades the NF-kappa B pathway and p38 and ERK MAPK activity in macrophages in vitro".ACTA PHARMACOLOGICA SINICA 33.10(2012):1293-1300. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。